Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors

por Kloth, J S L, Pagani, A, Verboom, M C, Malovini, A, Napolitano, C, Kruit, W H J, Sleijfer, S, Steeghs, N, Zambelli, A, Mathijssen, R H J
Publicado 2015

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours

por Lankheet, N A G, Kloth, J S L, Gadellaa-van Hooijdonk, C G M, Cirkel, G A, Mathijssen, R H J, Lolkema, M P J K, Schellens, J H M, Voest, E E, Sleijfer, S, de Jonge, M J A, Haanen, J B A G, Beijnen, J H, Huitema, A D R, Steeghs, N
Publicado 2014